Board
Prof. Peter Andrews PhD AO FTSE
Chairman
Australian biotech pioneer,
Implicit Bioscience co-founder and director.
Garry Redlich BA LLB DUniv
CEO & MD
Implicit Bioscience co-founder and director.
Peter Fry BSc
Director
Former president Reckitt Benckiser Pharma, Boots Pharma.
Lee Huntsman PhD
Non-Executive Director
Experienced company leader and corporate advisor.
Dr Stephen Hoffman MD PhD
Director
Highly accomplished biotechnology executive leader.
Stephen St Baker BAppSc
Director
Director of several companies in the energy industry.
Trevor St Baker AO
Alternate Director for Stephen St Baker
Respected executive leader and advocate in the energy and electricity industry.
Marion Koster BSc CPA
Chief Financial Officer & Company Secretary
Former ASX-listed biotech finance head.
Management
Dr Jan Agosti MD
Chief Medical Officer
Seattle
Dr Gordon Brandt MD
Director of Regulatory Affairs
Seattle
Garry Redlich BA LLB DUniv
Chief Executive Officer
Seattle, Brisbane
Marion Koster BSc CPA
Chief Financial Officer
Brisbane
Patrick Gearing PhD
Director CMC
Seattle
David Crowe PhD
VP Research
Seattle
Mark Appleby PhD
VP Preclinical
Seattle
Philip Wallace DPhil. MBA
VP Product & Business Development
Seattle
Brian Ziegelaar PhD
VP AU Ops
Brisbane
Patrick Charmley PhD
VP Projects & Program Management
Seattle
Clinical Investigators and Advisors
Prof. Ian Frazer AC MBChB MD FRS
Scientific Advisor
Brisbane
Prof. Merit Cudkowicz MD
Principal Scientist, ALS/MND phase 2
Healey Center, Mass. General/Harvard
Prof. Stanley Appel MD
Senior Neuroscience Advisor
Houston Methodist/Weill Cornell
A/Prof. Ivan Zanoni PhD
Senior Immunology Advisor
Boston Children’s/Harvard
Prof. Richard J. Ulevitch PhD
Senior Target Biology Consultant
San Diego
Prof. Erica Fletcher MSc PhD
Principal Investigator, Retinal Diseases
Visual Neurosciences/UniMelb
A/Prof. Robert Henderson MBBS PhD FRACP
Principal Investigator, ALS/MND
Royal Brisbane & Women’s/UniQld
Anjan Aralihalli MSc MBA
Venture Partner CTI Life Sciences, Board member Muscular Dystrophy Association
Neuromuscular Diseases
A/Prof. Kory Lavine MD PhD
Director of Cardiovascular Precision Medicine Research Initiative, Washington University School of Medicine in St Louis
Cardio-immunology
Prof. Antonio Abbate MD PhD
Professor of Cardiology, Virginia Commonwealth University
Cardio-immunology
Prof. Robyn Guymer AM, MBBS, PhD, FRANZCO, FAHMS
Deputy Director, Centre for Eye Research Australia, Professor of Surgery (Ophthalmology), University of Melbourne
Retinal Diseases
Thomas Hohman PhD
Former leader retinal translation programs at Allergan, Alcon, Novartis
Retinal Diseases
Prof. David Reutens MD FRACP
Principal Investigator, TBI/epilepsy
Centre for Advanced Imaging/UniQld
George Magrath, MD MBA
CEO Lexitas Pharma Services, Inc.
Retinal Diseases